Sun Pharma to acquire Nasdaq-listed oncology firm Checkpoint Therapeutics for $335 million
Checkpoint stockholders will also receive a contingent value right for up to $0.70 per share on achievement of certain milestone
Checkpoint stockholders will also receive a contingent value right for up to $0.70 per share on achievement of certain milestone
What's Your Reaction?
